Last Close
Feb 03  •  04:00PM ET
26.10
Dollar change
-0.34
Percentage change
-1.28
%
CategoryGlobal or ExUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsGlobal Return% 1Y- Total Holdings55 Perf Week-1.16%
SponsorPortfolio Building Block ETF Type Tagsequity Return% 3Y- AUM36.36M Perf Month3.12%
Fund Family Bond Type Tagshealthcare Return% 5Y- NAV/sh Perf Quarter-
IndexBITA Global Pharma and Biotech Sel Indx Average Maturity Tagspharmaceutical Return% 10Y 52W High27.08 -3.62% Perf Half Y-
Index Weighting Commodity Type Tagsbiotechnology Return% SI 52W Low24.18 7.92% Perf YTD3.40%
Active/Passive Quant Type Tags- Flows% 1M1952.18% Volatility0.93% 1.01% Perf Year-
Dividend TTM0.02 (0.09%) ESG Type Tags- Flows% 3M1952.18% ATR (14)0.31 Perf 3Y-
Dividend Ex-DateDec 24, 2025 Dividend Type Sector/Theme Flows% YTD1952.18% RSI (14)55.25 Perf 5Y-
Dividend Gr. 3/5Y- - Structure Type Region Flows% 1Y Beta- Perf 10Y-
Expense0.13% Growth/Value SMA200.76% Flows% 3Y Rel Volume0.95 Prev Close26.44
Inverse/Leveraged Market Cap SMA502.55% Flows% 5Y Avg Volume44.15K Price26.10
IPONov 25, 2025 Option/ShortNo / Yes SMA2002.55% Trades Volume41,987 Change-1.28%
Portfolio Building Block World Pharma And Biotech Index ETF seeks to track the performance, before fees and expenses, of the BITA Global Pharma and Biotech Select Index. The fund uses a "passive management" approach to track the performance, before fees and expenses, of the index. The index is constructed using a rules-based methodology that identifies companies in the pharmaceutical and/or biotechnology industries with publicly traded ordinary shares listed on major stock exchanges in developed markets, as classified by BITA GmbH. Under normal circumstances, the fund will invest at least 80% of the fund's net assets in component securities that make up the index. The fund is non-diversified.